FMAO
Farmers & Merchants Bancorp, Inc.
FMAO has a slight edge over GS overall, supported by stronger modeled upside and stronger fundamentals.
GS
The Goldman Sachs Group, Inc.
GS has slightly lower modeled downside risk, despite its lower overall score.
FMAO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FMAO's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FMAO.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
FMAO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $33.51 | -9.1% |
| Forward | 11x | $36.88 | — |
| Fair | 12x | $38.45 | +4.3% |
| Current | 12x | $36.88 | — |
| Expensive | 16x | $49.12 | +33% |
Historical ranges are pointers, not guarantees.
FMAO has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
FMAO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
FMAO has the edge over GS on the outlook, with more favorable valuation expectations.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
FMAO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.35 | +7.8% |
| Q3 2026 | $3.11 | +34% |
| Q2 2026 | $2.91 | +35% |
| Q1 2026 | $2.61 | +29% |
| Q4 2025 | $2.42 | +27% |
| Q3 2025 | $2.32 | +36% |
| Q2 2025 | $2.16 | +38% |
| Q1 2025 | $2.02 | +27% |
| Q4 2024 | $1.90 | +14% |
FMAO's earnings per share have climbed steadily: $3.11 over the past year, up 34% from the year before, and higher year over year for eight quarters in a row.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over FMAO on earnings, with stronger typical year-over-year growth.
FMAO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.8M | +11% |
| Q2 2026 | $34.4M | +16% |
| Q1 2026 | $32.4M | +16% |
| Q4 2025 | $32.5M | +21% |
| Q3 2025 | $31.3M | +22% |
| Q2 2025 | $29.6M | +18% |
| Q1 2025 | $28.1M | +17% |
| Q4 2024 | $26.9M | +13% |
FMAO's revenue has grown year over year for 10 quarters in a row: $35M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +4.9 points |
| Q2 2026 | 43% | +10 points |
| Q1 2026 | 38% | +6.8 points |
| Q4 2025 | 40% | +0.4 points |
| Q3 2025 | 36% | +4.2 points |
| Q2 2025 | 33% | +4.1 points |
| Q1 2025 | 31% | +3 points |
| Q4 2024 | 39% | +10 points |
FMAO has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
FMAO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.6M | +36% |
| Q2 2026 | $10.6M | +2651% |
| Q1 2026 | $7M | -34% |
| Q4 2025 | $13.2M | +604% |
| Q3 2025 | $10.7M | -41% |
| Q2 2025 | $385K | -96% |
| Q1 2025 | $10.6M | +740% |
| Q4 2024 | $1.9M | -78% |
FMAO has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
FMAO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +7.8K shares |
| 1 year | +0.3% | +41.6K shares |
| 3 years | +0.8% | +109K shares |
| 5 years | +22% | +2.5M shares |
| Available history | +22% | +2.5M shares |
FMAO has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.6M |
| Q2 2026 | $42,000 |
| Q1 2026 | $57,000 |
| Q4 2025 | $1,000 |
| Q3 2025 | $338,000 |
| Q2 2025 | — |
| Q1 2025 | $23,000 |
| Q4 2024 | — |
FMAO spent $2M buying back its own shares over the past year, about five times what it spent the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over FMAO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
FMAO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 3.1x | Elevated |
FMAO has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FMAO.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over FMAO on leverage, with a lower net debt burden relative to earnings.
FMAO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 74.3 | Neutral |
FMAO's weekly RSI is 71 (overbought) and its Stochastic is 74 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
FMAO PE vs Financial Services Sector
| Metric | FMAO | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 8.9% below |
| PE % | 39 | 63 | 24 pts below |
FMAO has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
FMAO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.8 | 3% above |
| 20 week MA | $34.3 | 7.5% above |
| 50 week MA | $29.8 | 24% above |
| 100 week MA | $27.5 | 34% above |
| 200 week MA | $25.4 | 45% above |
FMAO has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
FMAO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.7 | $23.0 | -25% |
| 2021 | $23.0 | $31.7 | +38% |
| 2022 | $31.7 | $27.8 | -12% |
| 2023 | $27.8 | $24.8 | -11% |
| 2024 | $24.8 | $28.6 | +15% |
| 2025 | $28.6 | $26.1 | -8.6% |
| 2026 YTD | $26.1 | $36.9 | +41% |
FMAO has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.